Clinical impact of multimodality assessment of myocardial viability.
CAD
cardiac magnetic resonance
coronary computed tomography
echocardiography
hibernating myocardium
myocardial viability
nuclear medicine
Journal
Echocardiography (Mount Kisco, N.Y.)
ISSN: 1540-8175
Titre abrégé: Echocardiography
Pays: United States
ID NLM: 8511187
Informations de publication
Date de publication:
Jul 2024
Jul 2024
Historique:
received:
02
05
2024
accepted:
20
05
2024
medline:
28
6
2024
pubmed:
28
6
2024
entrez:
28
6
2024
Statut:
ppublish
Résumé
Coronary artery disease (CAD) is a prevalent cause of left ventricular dysfunction. Nevertheless, effective elective revascularization, particularly surgical revascularization, can enhance long-term outcomes and, in selected cases, global left ventricular contractility. The assessment of myocardial viability and scars is still relevant in guiding treatment decisions and selecting patients who are likely to benefit most from blood flow restoration. Although the most recent randomized studies challenge the notion of "hibernating myocardium" and the clinical usefulness of assessing myocardial viability, the advancement of imaging techniques still renders this assessment valuable in specific situations. According to the guidelines of the European Society of Cardiology, non-invasive stress imaging may be employed to define myocardial ischemia and viability in patients with CAD and heart failure before revascularization. Currently, several non-invasive imaging techniques are available to evaluate the presence and extent of viable myocardium. The selection of the most suitable technique should be based on the patient, clinical context, and resource availability. This narrative review evaluates the characteristics of available imaging modalities for assessing myocardial viability to determine the most appropriate therapeutic strategy.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15854Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Knuuti J. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Russ J Cardiol. 2020;25:119‐180.
Panza JA, Ellis AM, Al‐Khalidi HR, et al. Myocardial viability and long‐term outcomes in ischemic cardiomyopathy. N Engl J Med. 2019;381:739‐748.
Heusch G, Schulz R. Characterization of hibernating and stunned myocardium. Eur Heart J. 1997;18(D):D102‐D110.
Kloner RA. Stunned and hibernating myocardium: where are we nearly 4 decades later? J Am Heart Assoc. 2020;9:e015502.
Ryan MJ, Perera D. Identifying and managing hibernating myocardium: what's new and what remains unknown? Curr Heart Fail Rep. 2018;15:214‐223.
Thijssen VLJL, Borgers M, Lenders M‐H, et al. Temporal and spatial variations in structural protein expression during the progression from stunned to hibernating myocardium. Circulation. 2004;110:3313‐3321.
Fallavollita JA, Canty JM. Differential 18F‐2‐deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion: evidence for chronic stunning in pigs. Circulation. 1999;99:2798‐2805.
Camici PG, Wijns W, Borgers M, et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation. 1997;96:3205‐3214.
Kalra DK, Zhu X, Ramchandani MK, et al. Increased myocardial gene expression of tumor necrosis factor‐α and nitric oxide synthase‐2. Circulation. 2002;105:1537‐1540.
Page BJ, Banas MD, Suzuki G, et al. Revascularization of chronic hibernating myocardium stimulates myocyte proliferation and partially reverses chronic adaptations to ischemia. J Am Coll Cardiol. 2015;65:684‐697.
Garcia MJ, Kwong RY, Scherrer‐Crosbie M, et al. State of the art: imaging for myocardial viability: a scientific statement from the American Heart Association. Circ Cardiovasc Imaging. 2020;13:e000053.
Yang X, Tian J, Zhang L, et al. Myocardial viability, functional status, and collaterals of patients with chronically occluded coronary arteries. Front Cardiovasc Med. 2021;8.
Pirnat M, Stillman AE, Rienmueller R, Noc M, Gorenjak M, Šeruga T. Can the degree of coronary collateralization be used in clinical routine as a valid angiographic parameter of viability? Int J Cardiovasc Imaging. 2021;37:379‐388.
Megaly M, Saad M, Tajti P, et al. Meta‐analysis of the impact of successful chronic total occlusion percutaneous coronary intervention on left ventricular systolic function and reverse remodeling. J Interv Cardiol. 2018;31:562‐571.
Mashayekhi K, Nührenberg TG, Toma A, et al. A randomized trial to assess regional left ventricular function after stent implantation in chronic total occlusion: the REVASC trial. JACC Cardiovasc Interv. 2018;11:1982‐1991.
Henriques JPS, Hoebers LP, Råmunddal T, et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial. J Am Coll Cardiol. 2016;68:1622‐1632.
De Bruyne B, Pijls NHJ, Bartunek J, et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation. 2001;104:157‐162.
Marchese N, Barbato E, Di Gioia G, et al. Intracoronary pressures to predict myocardial viability in patients with ischemic left ventricular dysfunction. Catheter Cardiovasc Interv. 2022;99:271‐279.
Foà A, Canton L, Bodega F, et al. Myocardial infarction with nonobstructive coronary arteries: from pathophysiology to therapeutic strategies. J Cardiovasc Med (Hagerstown). 2023;24:e134‐e146.
Armillotta M, Amicone S, Bergamaschi L, et al. Predictive value of Killip classification in MINOCA patients. Eur J Intern Med. 2023;117:57‐65.
Canton L, Fedele D, Bergamaschi L, et al. Sex‐ and age‐related differences in outcomes of patients with acute myocardial infarction: MINOCA vs. MIOCA. Eur Heart J Acute Cardiovasc Care. 2023;12:604‐614.
Paolisso P, Foà A, Bergamaschi L, et al. Impact of admission hyperglycemia on short and long‐term prognosis in acute myocardial infarction: MINOCA versus MIOCA. Cardiovasc Diabetol. 2021;20:192.
Pizzi C, Santarella L, Costa MG, et al. Pathophysiological mechanisms linking depression and atherosclerosis: an overview. J Biol Regul Homeost Agents. 2012;26:775‐782.
Paolisso P, Bergamaschi L, Rambaldi P, et al. Impact of admission hyperglycemia on heart failure events and mortality in patients with takotsubo syndrome at long‐term follow‐up: data from HIGH‐GLUCOTAKO investigators. Diabetes Care. 2021;44:2158‐2161.
Beleslin B, Ostojic M, Djordjevic‐Dikic A, et al. The value of fractional and coronary flow reserve in predicting myocardial recovery in patients with previous myocardial infarction. Eur Heart J. 2008;29:2617‐2624.
Hassell MECJ, Bax M, van Lavieren MA, et al. Microvascular dysfunction following ST‐elevation myocardial infarction and its recovery over time. EuroIntervention. 2017;13:e578‐e584.
Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539‐542.
Lang RM, Badano LP, Mor‐Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233‐270.
Paolisso P, Bergamaschi L, Santulli G, et al. Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2‐inhibitors: a multicenter international registry. Cardiovasc Diabetol. 2022;21:77.
Paolisso P, Foà A, Bergamaschi L, et al. Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA. Cardiovasc Diabetol. 2021;20:33.
Biagini E, Galema TW, Schinkel AFL, Vletter WB, Roelandt JRTC, Ten Cate FJ. Myocardial wall thickness predicts recovery of contractile function after primary coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2004;43:1489‐1493.
Picano E. Stress echocardiography: a historical perspective. Am J Med. 2003;114:126‐130.
Bergamaschi L, Pavon AG, Angeli F, et al. The role of non‐invasive multimodality imaging in chronic coronary syndrome: anatomical and functional pathways. Diagnostics (Basel). 2023;13:2083.
Bedetti G, Pasanisi EM, Pizzi C, et al. Economic analysis including long‐term risks and costs of alternative diagnostic strategies to evaluate patients with chest pain. Cardiovasc Ultrasound. 2008;6:21.
Almeida AG, Carpenter J‐P, Cameli M, et al. Multimodality imaging of myocardial viability: an expert consensus document from the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2021;22:e97‐e125.
Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG. American society of echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr. 2007;20:1021‐1041.
Picano E, Molinaro S, Pasanisi E. The diagnostic accuracy of pharmacological stress echocardiography for the assessment of coronary artery disease: a meta‐analysis. Cardiovasc Ultrasound. 2008;6:30.
Hirano Y, Amano M, Obokata M, Izumo M, Utsunomiya H. Practice guidance for stress echocardiography. J Echocardiogr. 2024;22:1‐15.
Manzoli L, Simonetti V, D'Errico MM, et al. (In)accuracy of blood pressure measurement in 14 Italian hospitals. J Hypertens. 2012;30:1955.
Karagiannis SE, Bax JJ, Elhendy A, et al. Enhanced sensitivity of dobutamine stress echocardiography by observing wall motion abnormalities during the recovery phase after acute beta‐blocker administration. Am J Cardiol. 2006;97:462‐465.
Senior R, Lahiri A. Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the “biphasic” response of wall thickening during low and high dose dobutamine infusion. J Am Coll Cardiol. 1995;26:26‐32.
Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Circulation. 1995;91:663‐670.
Hanekom L, Jenkins C, Jeffries L, et al. Incremental value of strain rate analysis as an adjunct to wall‐motion scoring for assessment of myocardial viability by dobutamine echocardiography. Circulation. 2005;112:3892‐3900.
Amundsen BH, Helle‐Valle T, Edvardsen T, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol. 2006;47:789‐793.
Gherbesi E, Gianstefani S, Angeli F, et al. Myocardial strain of the left ventricle by speckle tracking echocardiography: from physics to clinical practice. Echocardiography. 2024;41:e15753.
Altiok E, Tiemann S, Becker M, et al. Myocardial deformation imaging by two‐dimensional speckle‐tracking echocardiography for prediction of global and segmental functional changes after acute myocardial infarction: a comparison with late gadolinium enhancement cardiac magnetic resonance. J Am Soc Echocardiogr. 2014;27:249‐257.
Paolisso P, Bergamaschi L, Gragnano F, et al. Outcomes in diabetic patients treated with SGLT2‐Inhibitors with acute myocardial infarction undergoing PCI: the SGLT2‐I AMI PROTECT Registry. Pharmacol Res. 2023;187:106597.
Agati L, De Majo F, Madonna MP, Celani F, Funaro S, Tonti G. Assessment of myocardial viability in patients with postischemic left ventricular dysfunction: role of myocardial contrast echocardiography. Echocardiography. 2003;20(1):S19‐29.
Janardhanan R, Swinburn JMA, Greaves K, Senior R. Usefulness of myocardial contrast echocardiography using low‐power continuous imaging early after acute myocardial infarction to predict late functional left ventricular recovery. Am J Cardiol. 2003;92:493‐497.
Hickman M, Chelliah R, Burden L, Senior R. Resting myocardial blood flow, coronary flow reserve, and contractile reserve in hibernating myocardium: implications for using resting myocardial contrast echocardiography vs. dobutamine echocardiography for the detection of hibernating myocardium. Eur J Echocardiogr. 2010;11:756‐762.
Pellikka PA. Myocardial work as a metric of cardiac performance. J Am Soc Echocardiogr. 2023;36:1019‐1020.
Russell K, Eriksen M, Aaberge L, et al. A novel clinical method for quantification of regional left ventricular pressure–strain loop area: a non‐invasive index of myocardial work. Eur Heart J. 2012;33:724‐733.
Mahdiui ME, van der Bijl P, Abou R, et al. Myocardial work, an echocardiographic measure of post myocardial infarct scar on contrast‐enhanced cardiac magnetic resonance. Am J Cardiol. 2021;151:1‐9.
Kramer CM, Barkhausen J, Bucciarelli‐Ducci C, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson. 2020;22:17.
Bergamaschi L, Foà A, Paolisso P, et al. Prognostic role of early cardiac magnetic resonance in myocardial infarction with nonobstructive coronary arteries. JACC: Cardiovasc Imaging. 2023.
Mileva N, Paolisso P, Gallinoro E, et al. Diagnostic and prognostic role of cardiac magnetic resonance in MINOCA: systematic review and meta‐analysis. JACC: Cardiovasc Imaging. 2023;16:376‐389.
Pontone G, Carità P, Rabbat MG, et al. Role of cardiac magnetic resonance imaging in myocardial infarction. Curr Cardiol Rep. 2017;19:101.
Bergamaschi L, Landi A, Maurizi N, et al. Acute response of the noninfarcted myocardium and surrounding tissue assessed by T2 mapping after STEMI. JACC Cardiovasc Imaging. 2024;17(6):610‐621.
Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol. 1998;31:1040‐1048.
Kim Raymond J, Wu E, Rafael A, et al. The use of contrast‐enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445‐1453.
Weinsaft JW, Klem I, Judd RM. MRI for the assessment of myocardial viability. Cardiol Clin. 2007;25:35‐56.
D'Angelo T, Grigoratos C, Mazziotti S, et al. High‐throughput gadobutrol‐enhanced CMR: a time and dose optimization study. J Cardiovasc Magn Reson. 2016;19:83.
Lipinski MJ, McVey CM, Berger JS, Kramer CM, Salerno M. Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta‐analysis. J Am Coll Cardiol. 2013;62:826‐838.
Shah DJ, Kim HW, James O, et al. Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. JAMA. 2013;309:909‐918.
Pica S, Odoardo LD, Testa L, et al. Collateral presence and extent do not predict myocardial viability and ischemia in chronic total occlusions: a stress‐CMR study. Int J Cardiol. 2023;371:10‐15.
Patel AR, Salerno M, Kwong RY, Singh A, Heydari B, Kramer CM. Stress cardiac magnetic resonance myocardial perfusion imaging: JACC review topic of the week. J Am Coll Cardiol. 2021;78:1655‐1668.
Muscogiuri G, Ricci F, Scafuri S, et al. Cardiac magnetic resonance tissue characterization in ischemic cardiomyopathy. J Thorac Imaging. 2022;37:2‐16.
Heitner JF, Kim RJ, Kim HW, et al. Prognostic value of vasodilator stress cardiac magnetic resonance imaging: a multicenter study with 48 000 patient‐years of follow‐up. JAMA Cardiol. 2019;4:256‐264.
Gargiulo P, Dellegrottaglie S, Bruzzese D, et al. The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a meta‐analysis. Circ Cardiovasc Imaging. 2013;6:574‐582.
Shaaban M, Tantawy SW, Elkafrawy F, Romeih S, Elmozy W. Multiparametric rest and dobutamine stress magnetic resonance in assessment of myocardial viability. J Magn Reson Imaging. 2021;54:1773‐1781.
Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single‐photon emission computed tomography for diagnosis of coronary heart disease (CE‐MARC): a prospective trial. Lancet. 2012;379:453‐460.
Milano EG, Fuchs TA, Niero A, De Garate E, Baritussio A, Bucciarelli‐Ducci C. When and how to investigate myocardial viability in clinical practice. G Ital Cardiol (Rome). 2018;19:361‐370.
Bisi G, Sciagrà R, Santoro GM, Fazzini PF. Rest technetium‐99m sestamibi tomography in combination with short‐term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol. 1994;24:1282‐1289.
Katikireddy CK, Samim A. Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy. Clin Cardiol. 2022;45:152‐161.
Henzlova MJ, Cerqueira MD, Mahmarian JJ, Yao S‐S. Stress protocols and tracers. J Nucl Cardiol. 2006;13:e80‐e90.
Parikh K, Choy‐Shan A, Ghesani M, Donnino R. Multimodality imaging of myocardial viability. Curr Cardiol Rep. 2021;23:5.
Bedetti G, Pizzi C, Gavaruzzi G, Lugaresi F, Cicognani A, Picano E. Suboptimal awareness of radiologic dose among patients undergoing cardiac stress scintigraphy. J Am Coll Radiol. 2008;5:126‐131.
Katikireddy CK, Mann N, Brown D, Van Tosh A, Stergiopoulos K. Evaluation of myocardial ischemia and viability by noninvasive cardiac imaging. Expert Rev Cardiovasc Ther. 2012;10:55‐73.
Schindler TH, Schelbert HR, Quercioli A, Dilsizian V. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC: Cardiovasc Imaging. 2010;3:623‐640.
Jaarsma C, Leiner T, Bekkers SC, et al. Diagnostic performance of noninvasive myocardial perfusion imaging using single‐photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta‐analysis. J Am Coll Cardiol. 2012;59:1719‐1728.
Takx RAP, Blomberg BA, El Aidi H, et al. Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta‐analysis. Circ Cardiovasc Imaging. 2015;8:e002666.
Schinkel AFL, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol. 2007;32:375‐410.
Tsai J‐P, Yun C‐H, Wu T‐H, et al. A meta‐analysis comparing SPECT with PET for the assessment of myocardial viability in patients with coronary artery disease. Nucl Med Commun. 2014;35:947‐954.
Gewirtz H, Dilsizian V. Myocardial Viability. Circ Res. 2017;120:1197‐1212.
Pontone G, Rossi A, Guglielmo M, et al. Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging—part II. Eur Heart J Cardiovasc Imaging. 2022;23:e136‐e161.
Serruys PW, Kotoku N, Nørgaard BL, et al. Computed tomographic angiography in coronary artery disease. EuroIntervention. 2023;18:e1307‐e1327.
van Assen M, Vonder M, Pelgrim GJ, Von Knebel Doeberitz PL, Vliegenthart R. Computed tomography for myocardial characterization in ischemic heart disease: a state‐of‐the‐art review. Eur Radiol Exp. 2020;4:36.
Rodriguez‐Granillo GA. Delayed enhancement cardiac computed tomography for the assessment of myocardial infarction: from bench to bedside. Cardiovasc Diagn Ther. 2017;7:159‐170.
Mergen V, Sartoretti T, Klotz E, et al. Extracellular volume quantification with cardiac late enhancement scanning using dual‐source photon‐counting detector CT. Invest Radiol. 2022;57:406‐411.
Hamdy A, Kitagawa K, Goto Y, et al. Comparison of the different imaging time points in delayed phase cardiac CT for myocardial scar assessment and extracellular volume fraction estimation in patients with old myocardial infarction. Int J Cardiovasc Imaging. 2019;35:917‐926.
Mahnken AH, Bruners P, Mühlenbruch G, et al. Low tube voltage improves computed tomography imaging of delayed myocardial contrast enhancement in an experimental acute myocardial infarction model. Invest Radiol. 2007;42:123‐129.
Vignale D, Palmisano A, Gnasso C, et al. Extracellular volume fraction (ECV) derived from pre‐operative computed tomography predicts prognosis in patients undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J Cardiovasc Imaging. 2023;24:887‐896.
Sato A, Nozato T, Hikita H, et al. Prognostic value of myocardial contrast delayed enhancement with 64‐slice multidetector computed tomography after acute myocardial infarction. J Am Coll Cardiol. 2012;59:730‐738.
Beek AM, Kühl HP, Bondarenko O, et al. Delayed contrast‐enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol. 2003;42:895‐901.
Mahnken AH, Koos R, Katoh M, et al. Assessment of myocardial viability in reperfused acute myocardial infarction using 16‐slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol. 2005;45:2042‐2047.
Palmisano A, Vignale D, Benedetti G, Del Maschio A, De Cobelli F, Esposito A. Late iodine enhancement cardiac computed tomography for detection of myocardial scars: impact of experience in the clinical practice. Radiol Med. 2020;125:128‐136.
Chiou K‐R, Liu C‐P, Peng N‐J, et al. Identification and viability assessment of infarcted myocardium with late enhancement multidetector computed tomography: comparison with thallium single photon emission computed tomography and echocardiography. Am Heart J. 2008;155:738‐745.
van Assen M, Lavra F, Schoepf UJ, et al. Iodine quantification based on rest /stress perfusion dual energy CT to differentiate ischemic, infarcted and normal myocardium. Eur J Radiol. 2019;112:136‐143.
Ji Q, Wang Y, Zhao Y, et al. Evaluation of myocardial viability in patients with myocardial ischemia reperfusion injury using the dual‐energy CT myocardial blood pool imaging. Eur Radiol. 2023;33:3819‐3831.
Neumann F‐J, Sousa‐Uva M, Ahlsson A, et al. ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87‐165.
Bonow RO, Maurer G, Lee KL, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617‐1625.
Perera D, Clayton T, O'Kane PD, et al. Percutaneous revascularization for ischemic left ventricular dysfunction. N Engl J Med. 2022;387:1351‐1360.
Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta‐analysis. J Am Coll Cardiol. 2002;39:1151‐1158.
D'Egidio G, Nichol G, Williams KA, et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR‐2 trial. JACC Cardiovasc Imaging. 2009;2:1060‐1068.
Pica S, Di Giovine G, Bollati M, et al. Cardiac magnetic resonance for ischaemia and viability detection. Guiding patient selection to revascularization in coronary chronic total occlusions: the CARISMA_CTO study design. Int J Cardiol. 2018;272:356‐362.
van Loon RB, Veen G, Baur LHB, et al. Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI‐trial). Trials. 2012;13:1.